切换至 "中华医学电子期刊资源库"

中华老年病研究电子杂志 ›› 2014, Vol. 01 ›› Issue (01) : 34 -38. doi: 10.3877/cma.j.issn.2095-8757.2014.01.010

所属专题: 总编推荐 文献

临床研究

经颈内静脉肝内门腔静脉分流术治疗老年肝硬化门静脉高压症疗效分析
吴正忠1, 杨维竹1, 江娜1, 郑曲彬1, 黄兢姚1, 黄宁1   
  1. 1. 350001 福州,福建医科大学附属协和医院介入科
  • 收稿日期:2014-11-17 出版日期:2014-11-30

Cinical analysis of treatment for senile cirrhosis and portal hypertension after transjugular intrahepatic portosystemic stent shunt

Zhengzhong Wu1, Weizhu Yang1, Na Jiang1, Qubin Zheng1, Jingyao Huang1, Ning HUANG1   

  1. 1. Department of Interventional Radiology, Union Hospital, Fujian Medical Univercity, Fuzhou 350001, China
  • Received:2014-11-17 Published:2014-11-30
引用本文:

吴正忠, 杨维竹, 江娜, 郑曲彬, 黄兢姚, 黄宁. 经颈内静脉肝内门腔静脉分流术治疗老年肝硬化门静脉高压症疗效分析[J]. 中华老年病研究电子杂志, 2014, 01(01): 34-38.

Zhengzhong Wu, Weizhu Yang, Na Jiang, Qubin Zheng, Jingyao Huang, Ning HUANG. Cinical analysis of treatment for senile cirrhosis and portal hypertension after transjugular intrahepatic portosystemic stent shunt[J]. Chinese Journal of Geriatrics Research(Electronic Edition), 2014, 01(01): 34-38.

目的

探讨经颈内静脉肝内门腔静脉分流术(TIPSS)治疗老年肝硬化门静脉高压症的疗效。

方法

2008年1月至2014年6月福建医科大学附属协和医院选取老年肝硬化门静脉高压症患者119例,均经内科治疗无效后择期行TIPSS治疗。术后随访24个月,观察记录患者手术前后的门静脉压力,以及术后3,6,12,24个月再出血发生情况、腹水治疗情况、分流道狭窄发生情况。手术前后门静脉压力比较采用配对t检验,发生率的比较采用χ2检验。

结果

所有患者均成功置入支架建立分流道,其中75例采用Fluency覆膜支架,44例采用金属裸支架。患者TIPSS前后门静脉压力分别为(35.00±6.55)cmH2O及(20.92±6.63) cmH2O,差异有统计学意义(t=13.43,P<0.01)。术后3,6,12,24个月,36例顽固性腹水患者TIPSS后腹水完全缓解及部分缓解率分别为82.35%,84.85%,85.19%,76.00%;91例食管胃底静脉曲张破裂出血患者再出血发生率分别为5.49%,12.94%,22.72%,33.33%;119例患者分流道狭窄发生率分别为4.27%,10.00%,14.28%,24.19%。随访24个月,裸支架组狭窄率为47.73%,覆膜支架组狭窄率为17.33%,差异有统计学意义(χ2=12.55,P<0.01)。

结论

TIPSS具有疗效好、创伤小、操作时间短、并发症少、肝功能损害轻等优点,是老年肝硬化门静脉高压症的有效治疗手段;术中应用覆膜支架可能会明显降低支架狭窄发生率。

Objective

To evaluate the effect of transjuaular intrahepatic portosystemic stent shunt (TIPSS) in the treatment of senile cirrhosis and portal hypertension.

Methods

A retrospective analysis was reviewed on the 119 elder patients with senile cirrhosis and esophageal varices bleeding and refractory ascites. All of them underwent TIPSS after medical treatment fails. They were strictly followed up for 2 years and their clinical data were analysed. Color doppler imaging and shunt angiography were used to follow up patients to analyze the cases and type of stenosis.

Results

All patients were successfully implanted with stents (75 cases with the fluency stents, 44 cases with bare-metal stents)to establish shunt. Portal venous pressure from before TIPSS (35.00±6.55) cmH2O to after TIPSS (20.92±6.63) cmH2O(t=13.43, P<0.01). There is a significant difference. TIPSS after 3 months, 6 months, 12 months and 24 months ascites complete or partial remission rates were 82.35%, 84.85%, 85.19% and 76.00%, rebleeding rates were 5.49%, 12.94%, 22.72% and 33.33%, incidence of shunt stenosis were 4.27%, 10.00%, 14.28% and 24.19%. After 2-year follow-up, the bare stent group had 47.73% stenosis; the covered stent group had 17.33% (χ2=12.55, P<0.01). The difference between two groups was statistically significant.

Conclusion

TIPSS is available and satisfactory in the treatment of senile cirrhosis and portal hypertension, which has high efficacy. TIPSS is less invasive, takes shorter operation tim, causes fewer complications. Stenosis rate can be significantly decreased by the application of covered stent in TIPSS.

表1 36例乙肝肝硬化合并门静脉高压腹水患者TIPSS治疗后不同时期腹水缓解情况(例)
图1 患者男,70岁,经颈静脉肝内门腔静脉分流术后6个月复查,经支架直接门静脉造影显示支架肝静脉端狭窄,血流不通畅,近乎"盖帽"
[1]
Qin JP, Jiang MD, Tang W, et al. Clinical effects and complications of TIPS for portal hypertension due to cirrhosis: a single center[J]. World J Gastroenterol,2013,19(44):8085-8092.
[2]
Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis[J]. N Engl J Med,2010,362(9):823-832.
[3]
Qi X, Liu L, Bai M, et al. Transjugular intrahepatic portosystemic shunt in combination with or without variceal embolization for the prevention of variceal rebleeding: a meta-analysis[J]. J Gastroenterol Hepatol,2014,29(4):688-696.
[4]
García-Pagán JC, Bosch J. Early use of TIPS in patients with cirrhosis and variceal bleeding[J]. Ann Intern Med,2010,16,153(10):JC5-13.
[5]
Deipolyi AR, Kalva SP, Oklu R, et al. Reduction in portal venous pressure by transjugular intrahepatic portosystemic shunt for treatment of hemorrhagic stomal varices[J]. AJR Am J Roentgenol,2014,203(3):668-673.
[6]
Rossle M, Gerbes AL. TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update[J]. Gut,2010,59(7):988-1000.
[7]
Narahara Y, Kanazawa H, Fukuda T, et al. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial[J]. J Gastroenterol,2011,46(1):78-85.
[8]
Boyer TD, Haskal ZJ. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension: update 2009.American Association for the study of liver diseases[J]. Hepatology,2010,51(1):306.
[9]
贺平,李成杰,张紫寅,等.不同直径PTFE覆膜支架在门脉高压TIPSS术中的应用效果[J].海南医学,2013,24(19):2828-2831.
[10]
Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)[J]. Chest,2008,133(6 Suppl):454S-545S.
[11]
Bureau C, Pagan JC, Layrargues GP, et al. Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study[J]. Liver Int,2007,27(6):742-747.
[12]
Jung HS, Kalva SP, Greenfield AJ, et al. TIPS: comparison of shunt patency and clinical outcomes between bare stents and expanded polytetrafluoroethylene stent-grafts[J]. J Vasc Interv Radiol,2009,20(2):180-185.
[13]
鲍应军,顾俊鹏,纪卫政,等.PTFE覆膜支架与裸支架在TIPSS治疗门静脉高压症中的疗效比较[J].中国普通外科杂志,2014,23(1):83-86.
[14]
褚建国,孙晓丽,黄鹤,等.经皮经肝门腔静脉分流术[J].介人放射学杂志,2005,27(4):367-371.
[1] 李凤仪, 李若凡, 高旭, 张超凡. 目标导向液体干预对老年胃肠道肿瘤患者术后血流动力学、胃肠功能恢复的影响[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 29-32.
[2] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[3] 吴方园, 孙霞, 林昌锋, 张震生. HBV相关肝硬化合并急性上消化道出血的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 45-47.
[4] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[5] 刘跃刚, 薛振峰. 腹腔镜腹股沟疝日间手术在老年患者中的安全性分析[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 711-714.
[6] 代格格, 杨丽, 胡媛媛, 周文婷. 手术室综合干预在老年腹股沟疝患者中的应用效果[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 759-763.
[7] 韩宇, 张武, 李安琪, 陈文颖, 谢斯栋. MRI肝脏影像报告和数据系统对非肝硬化乙肝患者肝细胞癌的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 669-673.
[8] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[9] 姜里蛟, 张峰, 周玉萍. 多学科诊疗模式救治老年急性非静脉曲张性上消化道大出血患者的临床观察[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 520-524.
[10] 单秋洁, 孙立柱, 徐宜全, 王之霞, 徐妍, 马浩, 刘田田. 中老年食管癌患者调强放射治疗期间放射性肺损伤风险模型构建及应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 388-393.
[11] 秦维, 王丹, 孙玉, 霍玉玲, 祝素平, 郑艳丽, 薛瑞. 血清层粘连蛋白、Ⅳ型胶原蛋白对代偿期肝硬化食管胃静脉曲张出血的预测价值[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 447-451.
[12] 张雯, 宋牡丹, 邓雪婷, 张云. 强化营养支持辅助奥曲肽治疗肝硬化合并食管胃底静脉曲张破裂出血的疗效及再出血危险因素[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 456-460.
[13] 朱翔宇, 王建美, 张辉, 叶红英. 无创左心室压力-应变循环技术在左心室功能参数与肝硬化的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 494-498.
[14] 郭震天, 张宗明, 赵月, 刘立民, 张翀, 刘卓, 齐晖, 田坤. 机器学习算法预测老年急性胆囊炎术后住院时间探索[J]. 中华临床医师杂志(电子版), 2023, 17(9): 955-961.
[15] 孔凡彪, 杨建荣. 肝脏基础疾病与结直肠癌肝转移之间关系的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(07): 818-822.
阅读次数
全文


摘要